| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41c7996ac9ff4b636815c6f5403b6a4e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate |
2004-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_837f1bd1927e5ec3d6da7b95b563d074 |
| publicationDate |
2005-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-102004016355-A1 |
| titleOfInvention |
Preparation and Use of the Conjugate Methotrexate Albumin as an Immunosuppressant in GVHD |
| abstract |
ThenThe present invention relates to the use of drug-protein conjugatesnfor modulating and in particular for avoiding transplantation-associatednImmune reactions. Furthermore, the invention relates to a new, advantageousnManufacturing process fornthe inventively usablenConjugates. |
| priorityDate |
2004-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |